TickerFacts.

Fortrea Holdings Inc. (FTRE): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$113.50M
Year ended 2025-12-31
$227.80M
Trailing 12 months to 2026-06-30
+11.1%
3-year compound annual growth
$262.80M2021-12-31: $169.80M2022-12-31: $82.70M2023-12-31: $168.40M2024-12-31: $262.80M2025-12-31: $113.50M$113.50M
2021-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$113.50M-56.8%2026-02-26, From 2025-01-01
2024-12-31$262.80M+56.1%2026-02-26, From 2024-01-01
2023-12-31$168.40M+103.6%2026-02-26, From 2023-01-01
2022-12-31$82.70Mn/c2025-03-03, From 2022-01-01
2021-12-31$169.80Mn/a2024-03-13, From 2021-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Fortrea Holdings Inc. (FTRE)2025-12-31$113.50M-56.8%
Natera, Inc. (NTRA)2025-12-31$215.30M+58.7%
RadNet, Inc. (RDNT)2025-12-31$298.82M+28.2%
Guardant Health, Inc. (GH)2025-12-31-$184.76Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$83.16Mn/m
Quest Diagnostics Inc (DGX)2025-12-31$1.89B+41.4%
Labcorp Holdings Inc. (LH)2025-12-31$1.64B+3.4%
Veracyte, Inc. (VCYT)2025-12-31$136.31M+81.5%
CareDx, Inc. (CDNA)2025-12-31$42.03M+10.5%

Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗